A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myelomaMuzaffar H. Qazilbash, Larry W. Kwak, Medhavi Honhar et al.|Blood|2021Cited by 24
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-AutotransplantationMuzaffar H. Qazilbash, Larry W. Kwak, Edward A. Stadtmauer et al.|Blood|2016Cited by 8
Randomized phase II trial of combination idiotype vaccine and anti-CD3/anti-CD28 costimulated autologous T cells in patients with multiple myeloma post-autotransplantationMuzaffar H. Qazilbash, Larry W. Kwak, Edward A. Stadtmauer et al.|Experimental Hematology|2017Cited by 5
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-AutotransplantationMuzaffar H. Qazilbash, Larry W. Kwak, Edward A. Stadtmauer et al.|Clinical Lymphoma Myeloma & Leukemia|2017Cited by 0